Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • FITB vs GSK✓SelectedUSD · GSKFITB vs GSK performance historyLatest closeAs of-2.87%11/20
Stock and ETF performance explorer

FITB vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+35.1%
GSK return
+40.7%
Excess return
-5.6%
Maximum drawdown
-51.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.9%-0.1%-2.7%-2.8%
7D-9.4%-5.3%-4.0%-8.2%
30D-6.5%-3.7%-2.8%-5.7%
3M-8.6%-7.3%-1.4%-7.1%
6M+2.6%-4.2%+6.9%+3.4%
YTD+8.1%+0.9%+7.2%+7.5%
1Y+23.6%+7.3%+16.4%+21.3%
3Y+98.7%+52.7%+45.9%+72.6%
All+35.1%+40.7%-5.6%+7.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling